Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

INTRODUCTION: Adjuvant endocrine therapy induces bone loss and increases fracture risk in women with hormone-receptor positive, early-stage breast cancer (EBC). We aimed to update a previous position statement on the management of aromatase inhibitors (AIs) induced bone loss and now included premeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Waqas, Komal, Lima Ferreira, Joana, Tsourdi, Elena, Body, Jean-Jacques, Hadji, Peyman, Zillikens, M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080519/
https://www.ncbi.nlm.nih.gov/pubmed/33948427
http://dx.doi.org/10.1016/j.jbo.2021.100355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080519/
https://www.ncbi.nlm.nih.gov/pubmed/33948427
http://dx.doi.org/10.1016/j.jbo.2021.100355

Ejemplares similares